137 related articles for article (PubMed ID: 2443871)
21. Functional subtyping of muscarinic receptors on canine esophageal mucosa.
Lad R; Donoff B; Rangachari PK
Am J Physiol; 1991 Sep; 261(3 Pt 1):G464-9. PubMed ID: 1716057
[TBL] [Abstract][Full Text] [Related]
22. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
23. Muscarinic M1 receptor activation reduces maximum upstroke velocity of action potential in mouse right atria.
Islam MA; Nojima H; Kimura I
Eur J Pharmacol; 1998 Apr; 346(2-3):227-36. PubMed ID: 9652364
[TBL] [Abstract][Full Text] [Related]
24. Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
Micheletti R; Schiavone A
J Pharmacol Exp Ther; 1990 Apr; 253(1):310-4. PubMed ID: 1691785
[TBL] [Abstract][Full Text] [Related]
25. Prejunctional muscarinic (M1)-receptor interactions on guinea-pig ileum: lack of effect of cisapride.
Schuurkes JA; Van Bergen PJ; Van Nueten JM
Br J Pharmacol; 1988 May; 94(1):228-34. PubMed ID: 2456809
[TBL] [Abstract][Full Text] [Related]
26. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification.
Eglen RM; Kenny BA; Michel AD; Whiting RL
Br J Pharmacol; 1987 Apr; 90(4):693-700. PubMed ID: 2437988
[TBL] [Abstract][Full Text] [Related]
27. Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines.
Reid MS; Nishino S; Tafti M; Siegel JM; Dement WC; Mignot E
Exp Neurol; 1998 May; 151(1):89-104. PubMed ID: 9582257
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.
Black JW; Shankley NP
Br J Pharmacol; 1985 Nov; 86(3):609-17. PubMed ID: 2415197
[TBL] [Abstract][Full Text] [Related]
29. Contrasting effects of carbachol, McN-A-343 and AHR-602 on Ca(2+)-mobilization and Ca(2+)-influx pathways in taenia caeci.
Hishinuma S; Hongo I; Matsumoto Y; Narita F; Kurokawa M
Br J Pharmacol; 1997 Nov; 122(6):985-92. PubMed ID: 9401759
[TBL] [Abstract][Full Text] [Related]
30. Intracellular calcium release in N1E-115 neuroblastoma cells is mediated by the M1 muscarinic receptor subtype and is antagonized by McN-A-343.
Mathes C; Wang SS; Vargas HM; Thompson SH
Brain Res; 1992 Jul; 585(1-2):307-10. PubMed ID: 1380873
[TBL] [Abstract][Full Text] [Related]
31. Characterization of muscarinic receptors mediating relaxation and contraction in the rat iris dilator muscle.
Masuda Y; Yamahara NS; Tanaka M; Ryang S; Kawai T; Imaizumi Y; Watanabe M
Br J Pharmacol; 1995 Feb; 114(4):769-76. PubMed ID: 7539696
[TBL] [Abstract][Full Text] [Related]
32. Activation of M1/4 receptors phase advances the hamster circadian clock during the day.
Basu P; Wensel AL; McKibbon R; Lefebvre N; Antle MC
Neurosci Lett; 2016 May; 621():22-27. PubMed ID: 27063283
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein.
Pujol Lereis VA; Hita FJ; Gobbi MD; Verdi MG; Rodriguez MC; Rothlin RP
Br J Pharmacol; 2006 Mar; 147(5):516-23. PubMed ID: 16444291
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological basis for functional selectivity of partial muscarinic receptor agonists.
Heldman E; Barg J; Fisher A; Levy R; Pittel Z; Zimlichman R; Kushnir M; Vogel Z
Eur J Pharmacol; 1996 Feb; 297(3):283-91. PubMed ID: 8666061
[TBL] [Abstract][Full Text] [Related]
35. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
Forray C; el-Fakahany EE
Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
[TBL] [Abstract][Full Text] [Related]
36. An excitatory muscarinic response in neonatal rat ventricular myocytes and its modulation by sympathetic innervation.
Sun LS; Vulliemoz Y; Huber F; Bilezikian JP; Robinson RB
J Mol Cell Cardiol; 1994 Jun; 26(6):779-87. PubMed ID: 7522276
[TBL] [Abstract][Full Text] [Related]
37. McN-A-343, a specific agonist of M1-muscarinic receptors, exerts antinicotinic and antimuscarinic effects in the rat adrenal medulla.
Wakade AR; Kahn R; Malhotra RK; Wakade CG; Wakade TD
Life Sci; 1986 Dec; 39(22):2073-80. PubMed ID: 2431246
[TBL] [Abstract][Full Text] [Related]
38. Effects of McN-A-343 on insect neurosecretory cells: evidence for muscarinic-like receptor subtypes.
Lapied B; Tribut F; Hue B
Neurosci Lett; 1992 May; 139(2):165-8. PubMed ID: 1376877
[TBL] [Abstract][Full Text] [Related]
39. Muscarinic receptor subtypes mediating vasodilation and vasoconstriction in isolated, perfused simian coronary arteries.
Ren LM; Nakane T; Chiba S
J Cardiovasc Pharmacol; 1993 Dec; 22(6):841-6. PubMed ID: 7509902
[TBL] [Abstract][Full Text] [Related]
40. Evidence for muscarinic M4 receptors mediating nonadrenergic noncholinergic relaxations in rabbit anococcygeus muscle.
Gross J; Mutschler E; Lambrecht G
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):505-16. PubMed ID: 9349639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
